Blood Cancer Patients To Benefit From Ambitious Project

Share this article
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.
A collaboration between the University of York, the NHS and 14M Genomics, has launched a project to analyse samples from over 20,000 blood cancer patients. The study aims to understand how genetic differences in cancer cells affects treatment.
The study is being run through the Haematological Malignancy Research Network (HMRN), funded by the charity Leukaemia & Lymphoma Research. HMRN has compiled extensive data on over 20,000 patients, recording treatment, response and outcome information to clinical standards.
14M Genomics will be running the sequencing and analysis. The genomic and phenotypic data will be built into a database, creating an invaluable resource for doctors looking to recommend the most effective line of treatment for patients.
For the full story, please visit Leukaemia & Lymphoma Research

Leave a reply